![Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire](https://mms.businesswire.com/media/20210831005934/en/902034/23/MedinCell_LOGO.jpg)
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire
![Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire](https://mms.businesswire.com/media/20210408005437/en/868792/5/Teva_Canada_-_AJOVY_Autoinjector.jpg)
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire
![Impact of the COVID-19 pandemic on non-COVID-19 hospital mortality in patients with schizophrenia: a nationwide population-based cohort study | Molecular Psychiatry Impact of the COVID-19 pandemic on non-COVID-19 hospital mortality in patients with schizophrenia: a nationwide population-based cohort study | Molecular Psychiatry](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41380-022-01803-4/MediaObjects/41380_2022_1803_Fig1_HTML.png)
Impact of the COVID-19 pandemic on non-COVID-19 hospital mortality in patients with schizophrenia: a nationwide population-based cohort study | Molecular Psychiatry
![Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record](https://www.enr.com/ext/resources/Issues/MidAtlantic_Issues/2018/10-October/22-Oct/teva-pilot-plant01.jpg)
Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
![Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe | Fierce Pharma Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1513259678/Teva.jpg/Teva.jpg?VersionId=X.bfLOFDA2JJoB_iZZsS2c.P4rdVOo7P)